Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China
NCT Number: NCT01372189
The study aims to:
1. Achieve molecular imaging of EGFR in patients with colorectal neoplasia in vivo using confocal laser endomicroscopy. 2. Compare the results of in vivo EGFR-specific molecular imaging with CLE and ex vivo immunohistochemistry .
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Jinan, Shandong, China
Various kinds of tumor markers have been shown to be over-expressed in colorectal cancer, including epidermal growth factor receptor(EGFR). The conventional detection method of EGFR expression in colorectal neoplasia is immunohistochemistry which is time-consuming, and the immunoreactivity can be affected by storage and fixation of tissues. Confocal laser endomicrosopy is a newly developed device which could identify the cellular and subcellular structures clearly with the magnification at×1000, making it possible to explore the physiological and pathological molecular mechanism of the gastrointestinal tract. So the study aims to achieve molecular imaging of EGFR in colorectal neoplasia in vivo using confocal laser endomicroscopy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
:
●Patients known to have large polypoid lesions in colon or rectum from previous examinations from outpatients and inpatients at Qilu Hospital were enrolled into the study
Exclusion criteria
Shandong University
Other
In Vivo Molecular Imaging of Epidermal Growth Factor Receptor in Patients With Colorectal Neoplasia Using Confocal Laser Endomicroscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07678099
Breast Cancer, Breast Diseases
Istanbul, Uskudar, Turkey (Türkiye)
View Trial DetailsNCT07321548
Colonic Diseases, Colorectal Adenoma
Hong Kong
View Trial DetailsNCT04636619
Colonic Diseases, Colonic Polyp
Valladolid, Spain
View Trial DetailsNCT05740137
Colonic Diseases, Colorectal Adenoma
Holbæk, Denmark
View Trial Details